Akorn (AKRX) PT Lowered to $2 at RBC Capital Feb 28, 2020 06:24AM
Akorn (AKRX) Management Meetings Imply 2020 Expectations Are an Easy Hurdle - RBC Capital Aug 13, 2019 07:03AM
RBC Capital Sees Akorn (AKRX) Margins Regaining mid-40s% May 30, 2019 09:08AM
Akorn to Present at the RBC Capital Markets Healthcare Conference May 20, 2019 08:01AM
Akorn (AKRX) PT Raised to $5 at RBC Capital; 'Early Turnaround Encouraging' May 8, 2019 06:44AM


Mar 1, 2019 06:37AM Akorn (AKRX) PT Lowered to $4 at RBC Capital
Jan 9, 2019 11:59AM Akorn (AKRX) FDA Warning Letter was a 'Known Risk' - RBC
Dec 10, 2018 06:46AM Akorn (AKRX) PT Lowered to $6 at RBC Capital
Dec 6, 2018 11:55AM Akorn (AKRX) Plunges as Hopes in Delaware Trial Sinks
Nov 26, 2018 03:40PM Akorn (AKRX) Generic Voltaren Gel Approved - RBC
Nov 7, 2018 06:59AM Akorn (AKRX) PT Lowered to $9 at RBC Capital
Oct 2, 2018 07:17AM Akorn (AKRX) PT Lowered to $10 at RBC Capital
Oct 1, 2018 10:17AM Akorn (AKRX) 'Worst-Case Scenario', Stock Could Settle ~$6-$8 Today - RBC
Aug 21, 2018 07:00AM Akorn (AKRX): Post-Trial Hearing Could Signal Direction of Decision - RBC
Jul 25, 2018 07:30AM Akorn (AKRX) PT Raised to $27 at RBC Capital on Higher Likelihood of Deal Closure
Jul 17, 2018 02:54PM Akorn (AKRX) Risk/Reward Still Favorable - RBC
May 24, 2018 09:04AM RBC Has an Unchanged View on Akorn (AKRX) Merger Following Expert Call
May 23, 2018 09:58AM RBC Still Sees a Path to Closing of Akorn (AKRX) Merger
Apr 27, 2018 12:22PM Akorn (AKRX) Gains as RBC Sees a Path to Closing
Mar 29, 2018 07:06AM RBC Capital Likes Akorn (AKRX) Upside Risk/Reward from Here; PT Lowered to $25
Aug 18, 2017 08:01AM Akorn (AKRX): Takeout Price Hard To Justify, Repricing Could Happen - RBC
Apr 10, 2017 07:22AM Akorn (AKRX): Valuation Here Is Fair, More Is Compelling - RBC
Apr 7, 2017 03:37PM RBC Capital Reiterates Sector Perform Rating on Akorn (AKRX) Following Reports Fresenius in Take-Out Discussions
Mar 2, 2017 06:57AM Akorn (AKRX) PT Lowered to $21 at RBC Capital on 2017 Guidance 'Reset' and 'Struggle With Growth Story'
Nov 4, 2016 06:13AM RBC Capital Downgrades Akorn (AKRX) to Sector Perform
Sep 15, 2016 10:27AM Notable Analyst Rating Changes 9/15: (GPN) (AKRX) (EXTR) Upgraded; (VFC) (FGP) (ATRA) Downgraded
Jul 19, 2016 06:43AM Akorn (AKRX): EPS Upside Coming From Competitor Delay - RBC
Jul 18, 2016 01:02PM Akorn (AKRX) Ephedrine NDA Delayed - RBC Capital
Jul 18, 2016 01:01PM RBC Remains Positive on Akorn (AKRX) as Ephedrine NDA Still Not Approved
Jul 11, 2016 10:47AM Akorn (AKRX) Highlighted at RBC After Sagent (SGNT) Acquired by Foreign Player
May 17, 2016 06:31AM Akorn (AKRX) Lack of Disaster Brings Pipeline Into Focus - RBC
Feb 12, 2016 07:45AM RBC Capital Cuts Price Target on Akorn (AKRX) Ahead of March Update
Jan 19, 2016 06:57AM RBC Highlights Bull Case and Milestones for Akorn (AKRX)
Jan 12, 2016 12:56PM Akorn (AKRX) Provided Realistic Outlook on Path to Re-File - RBC Capital
Nov 5, 2015 08:17AM Akorn (AKRX) to Request NASDAQ Filing Extension; RBC Capital Reiterates Outperform
Sep 29, 2014 10:50AM Notable Analyst Rating Changes 9/29: (AKRX) (CHS) (NKE) Upgraded; (DRC) (MAT) (KS) Downgraded
Sep 29, 2014 06:32AM RBC Capital Upgrades Akorn (AKRX) to Outperform
Jan 7, 2014 07:00AM RBC Capital Starts Akorn (AKRX) at Sector Perform
Jan 28, 2013 06:58AM RBC Capital Upgrades Akorn (AKRX) to Sector Perform